Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
As it does so, a 3D printer system prints a rigid back structure to the blanket array membrane. As it does so, the hard UV radiation of space rapidly cures the resin, making it hard. This means a ...
Over the past decades, a growing number of robotics teams have started developing modular robots inspired by the ancient paper-folding art of origami. More recently, some of these teams started ...
Albany International Initiates Review of Strategic Alternatives for Structures Assembly Business; Announces Loss Reserve Adjustment for CH-53K Program; Schedules Earnings Release Date Third-Quarter ...
DEMLab is a MATLAB program for performing numerical simulations of particle systems using the Discrete Element Method (DEM). Its purpose is to offer a modular and extensible environment that allows ...
Strong financial position with cash, cash equivalents and short-term investments of $786.5 million as of June 30, 2025 expected to fund projected operations and key clinical milestones through at ...
ARRAY Technologies, Inc. announced the successful closing of a private offering of $345 million in convertible senior notes due July 2031, with net proceeds of approximately $334 million. The company ...
Lockheed Martin's Lunar Vertical Solar Array Technology (LVSAT) prototype underwent a variety or testing at Lockheed Martin Space's Littleton, Colorado facility. Credit: Lockheed Martin WASHINGTON — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback